Invention Grant
- Patent Title: Kinase inhibitor polymorphs
- Patent Title (中): 激酶抑制剂多晶型物
-
Application No.: US14357144Application Date: 2012-11-12
-
Publication No.: US09403820B2Publication Date: 2016-08-02
- Inventor: Pingda Ren , Michael Martin , Christopher Peter Worrall , Susanna del Rio Gancedo
- Applicant: INTELLIKINE LLC
- Applicant Address: US CA La Jolla GB
- Assignee: Intellikine LLC,Sigma-Aldrich Company Limited
- Current Assignee: Intellikine LLC,Sigma-Aldrich Company Limited
- Current Assignee Address: US CA La Jolla GB
- Agency: Honigman Miller Schwartz and Cohn LLP
- Agent Lucy X. Yang; Jonathan P. O'Brien
- International Application: PCT/US2012/064729 WO 20121112
- International Announcement: WO2013/071272 WO 20130516
- Main IPC: C07D471/04
- IPC: C07D471/04
Abstract:
Polymorphs of chemical compounds that modulate kinase activity, including PI3K activity, and chemical compounds, pharmaceutical compositions, and methods of treatment of diseases and conditions associated with kinase activity, including PI3K activity, are described herein.
Public/Granted literature
- US20150005301A1 KINASE INHIBITOR POLYMORPHS Public/Granted day:2015-01-01
Information query
